C6 and U251 glioma cells were treated with ML130, a NOD1 inhibitor, and assessed using 5‐ethynyl‐2′‐deoxyuridine (EdU), plate cloning, Transwell, and wound healing assays. The gene discussed is NOD1; the disease is central nervous system cancer.